News About: Pharm. Affairs
‘Champix’ extended in usage by gradual smoking cessation
On the 12th, Champix(generic name: varenicline tartrate), a Pfizer Pharmaceuticals Korea’s(CEO/President Dong-Wook Oh) supportive therapy of quitting smoking, was approved from the Ministry of Food and Drug Safety for...
“Saudi Arabia is considering a 30-approval process for Korean drugs”
“We are considering a 30-day approval process for pharmaceutical products that are already approved from the Korean Ministry of Food and Drug Safety.”
Mr. Al-Hariri, a person in charge for pharmaceutical affairs in S...
Will AI be used in new drug development in Korea?
Will new drug development using artificial intelligence(AI) take a first step in Korea?
On the 14th, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(Chairman Hee-Mok Won, KPBMA) had a demand survey,...
Pentavalent combination vaccine ‘DTaP-IPV/Hib’ introduced in Korea
A pentavalent vaccine(DTaP-IVP/Hib), which prevent diphtheria, tetanus, whooping cough, polio and haemophilus influenzae type b, will be introduced.
The Korea Centers for Disease Control and Prevention(Director Ki-Su...
Korean glooming product market exceeds KRW 1.2 trillion in 2016
Grooming, a trend among men investing time and efforts into taking care of their appearance, is evolving gradually.
In the past, men, who through it was good enough with skin and lotion after washing their face, are ...
“Public enemy, ‘find dust,’ affects chronic obstructive pulmonary disease(COPD)”
A study was reported that ‘fine dust,’ a public enemy that threatens respiratory health of modern people, causes and worsen chronic obstructive pulmonary disease(COPD) on human body. Smoking is the main risk factor of...
Ibrance rejected for health insurance benefits
The registration of Ibrance Cap(Pfizer Pharmaceuticals Korea), a breast cancer treatment, for the health insurance benefits fell through.
The Health Insurance Benefit Evaluation Committee conducted an health insuranc...
Foundation of herbal medicine company is in danger
The foundation of pharmaceutical companies specializing in manufacturing of herbal medicines, such as granules and medicinal soups, has been in danger.
These pharmaceutical companies have frequently cause trouble of ...
Basic dispensing fee stays same at KRW 1,360 in 2018, KRW 5,460 for 3-day prescription
The 2018 medical fee negotiation for pharmacy drew a result of a 2.9% increase; the equivalent index, a unit cost per relative value point, was KRW 82.4.
Based on a calculation of 2018’s pharmacy dispensing fees by a...
Emergency Household Product Deliberation Committee postpones 3rd meeting, “Delay was inevitable”
The Emergency Household Product Deliberation Committee postponed the 3rd meeting that is considered as their last meeting.
At the 3rd meeting which was scheduled on the coming 7th, it was planned to categorize therap...
